0001140361-17-012952.txt : 20170322 0001140361-17-012952.hdr.sgml : 20170322 20170322170037 ACCESSION NUMBER: 0001140361-17-012952 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170320 FILED AS OF DATE: 20170322 DATE AS OF CHANGE: 20170322 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc. CENTRAL INDEX KEY: 0001636282 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464312787 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 901 S. MOPAC EXPRESSWAY, STE. 250 STREET 2: BARTON OAKS PLAZA ONE CITY: AUSTIN STATE: TX ZIP: 78746 BUSINESS PHONE: (512) 942-2935 MAIL ADDRESS: STREET 1: 901 S. MOPAC EXPRESSWAY, STE. 250 STREET 2: BARTON OAKS PLAZA ONE CITY: AUSTIN STATE: TX ZIP: 78746 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: York Charles N II CENTRAL INDEX KEY: 0001655962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37722 FILM NUMBER: 17707291 MAIL ADDRESS: STREET 1: 901 S. MOPAC EXPRESSWAY STREET 2: BARTON OAKS PLAZA ONE, SUITE 250 CITY: AUSTIN STATE: TX ZIP: 78746 4 1 doc1.xml FORM 4 X0306 4 2017-03-20 0 0001636282 Aeglea BioTherapeutics, Inc. AGLE 0001655962 York Charles N II 901 S. MOPAC EXPRESSWAY BARTON OAKS PLAZA ONE, SUITE 250 AUSTIN TX 78746 0 1 0 0 Chief Financial Officer and VP Employee Stock Option (right to buy) 8.03 2017-03-20 4 A 0 90000 0 A 2027-03-19 Common Stock 90000 90000 D The stock option vests and becomes exercisable in 48 equal monthly installments beginning on April 20, 2017, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. /s/ Charles N. York II 2017-03-22